Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Citi
Johnson and Johnson
UBS
Teva
QuintilesIMS
Federal Trade Commission
Merck

Generated: April 20, 2018

DrugPatentWatch Database Preview

LORELCO Drug Profile

« Back to Dashboard

Which patents cover Lorelco, and when can generic versions of Lorelco launch?

Lorelco is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in LORELCO is probucol. There are six drug master file entries for this compound. Additional details are available on the probucol profile page.
Drug patent expirations by year for LORELCO
Medical Subject Heading (MeSH) Categories for LORELCO
Synonyms for LORELCO
2,6-bis(tert-butyl)-4-{1-[3,5-bis(tert-butyl)-4-hydroxyphenylthio]-isopropylth io}phenol
2,6-di-tert-butyl-4-({2-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulfanyl]propan-2-yl}sulfanyl)phenol
2,6-di-tert-butyl-4-(2-(3,5-di-tert-butyl-4-hydroxyphenylthio)propan-2-ylthio)phenol
2,6-Di-tert-butyl-4-[1-(3,5-di-tert-butyl-4-hydroxy-phenylsulfanyl)-1-methyl-ethylsulfanyl]-phenol
2,6-di(tert-butyl)-4-[(1-{[3,5-di(tert-butyl)-4-hydroxyphenyl]sulfanyl}-1-methylethyl)sulfanyl]phenol
2,6-di(tert-butyl)-4-{1-[3,5-di(tert-butyl)-4-hydroxyphenylsulfanyl]-1-methylethylsulfanyl}phenol
2,6-di(tert-butyl)-4-{1-[3,5-di(tert-butyl)-4-hydroxyphenylsulfanyl]-1-methylethylsulfanyl}phenol(probucol)
2,6-Ditert-butyl-4-((1-[(3,5-ditert-butyl-4-hydroxyphenyl)sulfanyl]-1-methylethyl)sulfanyl)phenol #
2,6-ditert-butyl-4-[1-(3,5-ditert-butyl-4-hydroxy-phenyl)sulfanyl-1-methyl-ethyl]sulfanyl-phenol
2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol
23288-49-5
288P495
4,4'- (Isopropylidenedithio)bis(2, 6-di-tert-butylphenol)
4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)
4,4'-(Isopropylidenedithio)bis(2, 6-di-tert-butylphenol)
4,4'-(Isopropylidenedithio)bis(2,6-di-tert-butylphenol)
4,4'-(Isopropylidenedithio)bis[2, 6-di-tert-butylphenol]
4,4'-(Isopropylidenedithio)bis[2,6-di-tert-butylphenol]
4,4'-(propane-2,2-diylbis(sulfanediyl))bis(2,6-di-tert-butylphenol)
4,4'-(propane-2,2-diyldisulfanediyl)bis(2,6-di-tert-butylphenol)
4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]
4,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)phenol]
AB00052202
AB00052202_14
AB00052202_15
AB2000521
AC1L1J88
Acetone bis(3,5-di-t-butyl-4-hydroxyphenyl) mercaptole
Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Acetone, bis (3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Acetone, bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Acetone,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
AK163570
AKOS001740866
Almirall Brand of Probucol
API0003932
Aventis Brand of Probucol
BDBM50007260
BG0666
Biphenabid
Bisbid
Bisphenabid
BPBio1_000625
BRD-K72029282-001-04-8
BRN 2026253
BSPBio_000567
BSPBio_003176
C-23041
C07373
C31H48O2S2
CAS-23288-49-5
CC-33926
CCG-38986
CCRIS 7510
CHEBI:8427
CHEMBL608
CJ-24018
cMAP_000039
CS-2473
CTK8G2582
D00476
D0H2DQ
DB01599
DE-3872
DH 581
DH-581
DH581
DivK1c_000599
DR003132
DSSTox_CID_25440
DSSTox_GSID_45440
DSSTox_RID_80881
DTXSID2045440
EINECS 245-560-9
FT-0630498
FYPMFJGVHOHGLL-UHFFFAOYSA-N
GTPL7277
HMS1569M09
HMS1921D21
HMS2092D05
HMS2096M09
HMS2233C08
HMS3655P19
HMS501N21
Hoechst Brand of Probucol
HY-B0388
I14-31835
IDI1_000599
KBio1_000599
KBio2_001776
KBio2_002394
KBio2_004344
KBio2_004962
KBio2_006912
KBio2_007530
KBio3_002396
KBio3_002873
KBioGR_000708
KBioGR_002394
KBioSS_001776
KBioSS_002399
KS-00000XMC
KS-1459
Lesterol
LORELCO (TN)
LS-13188
Lursell
Lurselle
MCULE-4445301513
MFCD00079281
MLS000028492
MolPort-002-042-265
NCGC00016777-01
NCGC00016777-02
NCGC00016777-03
NCGC00016777-04
NCGC00016777-05
NCGC00016777-07
NCGC00016777-08
NCGC00094895-01
NCGC00094895-02
NCGC00094895-03
NCGC00094895-04
NINDS_000599
NSC 652160
NSC 86225
NSC-652160
NSC-757837
NSC-86225
NSC652160
NSC757837
NSC86225
Opera_ID_1820
OR245325
P2002
P3CTH044XJ
Panavir
Pharmakon1600-01501109
phenbutol
Phenol, 4,4'-((1-methylethylidene)bis(thio))bis(2,6-bis(1,1-dimethylethyl)-
Phenol, 4,4'-((1-methylethylidene)bis(thio))bis(2,6-bis(1,1-dimethylethyl))-
Phenol, 4,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)-
Phenol,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)-
Prestwick_408
Prestwick0_000384
Prestwick1_000384
Prestwick2_000384
Prestwick3_000384
probucol
Probucol (JAN/USP/INN)
Probucol (JP17/USP/INN)
Probucol [USAN:BAN:INN:JAN]
Probucol [USAN:USP:INN:BAN:JAN]
Probucol, analytical standard
Probucol, United States Pharmacopeia (USP) Reference Standard
Probucolum
Probucolum [INN-Latin]
PubChem17621
S-8042
s2119
SBB001675
SBI-0051640.P002
SC-47042
SCHEMBL4150
Serterol
Sinlestal
SMR000058265
SPBio_001420
SPBio_002488
Spectrum_001296
SPECTRUM1501109
Spectrum2_001400
Spectrum3_001438
Spectrum4_000414
Spectrum5_001343
SR-01000695447
SR-01000695447-2
ST075698
STK762566
Superlipid
Tox21_110605
Tox21_110605_1
UNII-P3CTH044XJ
W-107409
Z1551900339
ZERO/001429
ZINC1530755

US Patents and Regulatory Information for LORELCO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-002 Jul 6, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LORELCO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-002 Jul 6, 1988 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Chinese Patent Office
AstraZeneca
US Department of Justice
Cipla
Fish and Richardson
Chubb
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.